Beijing, China · Founded 2018 · In IPO Registration
Developer of innovative drugs for tumor treatment. Avistone Pharmaceuticals Biotechnology is based in Beijing, China and was founded in 2018. Its last reported valuation was $628 million in Mar 2025. It has raised $372 million.
Last reported valuation
$628.3M
Oct 2026
Priced at
—
Total raised
$372.0M
Last round
—
Cap table — not yet on record
Avistone Pharmaceuticals Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Avistone Pharmaceuticals Biotechnology with a free account
·The complete investor list: 11 names
·Watch Avistone Pharmaceuticals Biotechnology: the Monday email on marks, rounds and moves
